Inhibitor of differentiation or DNA binding-1 (ID1) is an important helix-loophelix (HLH) transcription factor involved in diverse biological functions including cell differentiation, proliferation, apoptosis, and senescence. Recently, it was reported that ID1 can activate the NF-B signaling pathway in a variety of cancer cells and a T cell line, but the mechanisms involved in ID1-mediated transactivation of NF-B are not clear. In this study, we demonstrate by both in vitro pull-down assays and a cell-based in vivo two-hybrid system that ID1-mediated NF-B activation is due to its physical interaction with p65. We have identified that the transcriptional activation domain (TAD) in p65 and the HLH domain in ID1 are vital for their interaction. Interestingly, a single site mutation (Leu76) in the HLH domain of ID1 protein drastically decreased its ability to bind with p65. Using a dualluciferase assay, we demonstrated that the interaction between ID1 and p65 modulates activation of the NF-B signaling pathway in vivo. In addition, we demonstrated that, by affecting the nuclear translocation of p65, ID1 is essential in regulating TNF-␣-induced p65 recruitment to its downstream target, the cellular inhibitor of apoptosis protein 2 (cIAP2) promoter.
INHIBITOR OF DIFFERENTIATION OR DNA BINDING-1 (ID1) is a member of the ID protein superfamily, which consists of ID1 to ID4 and belongs to the helix-loop-helix (HLH) transcription factor family (2) . Besides the HLH domain, the basic HLH family members usually contain a DNA binding domain and play roles in transcriptional regulation via binding to DNA as either homodimers or heterodimers (2) . Since ID protein lacks a DNA binding domain, it forms inactive heterodimers with other basic HLH proteins and consequently acts as a negative regulator of other HLHs (2, 30) . As a ubiquitously expressed gene in multiple tissues, ID1 functions in diverse cellular processes, including cell differentiation, proliferation, apoptosis, and senescence (30, 35, 46, 50) . Recent studies have suggested that ID1 may be an oncogene and plays a critical role in promoting tumor development and invasion, as its expression is high in a variety of human cancers, including cancer of the pancreas (29) , thyroid (19) , breast (25) , cervix (38) , ovary (39) , prostate (33) , esophagus (15) , blood (43) , and lung (4, 37) . High expression levels of ID1 have been associated with a poorer prognosis in various cancers (9, 39, 40, 43) . ID1 has been shown to promote cell proliferation and survival in cancer cells (16, 21, 23, 26, 45) . High ID1 protein levels may confer higher invasiveness in human cancers (8, 24, 25) . Thus the evidence for an important role of ID1 in cancer development and progression seems to be growing (27) .
The mechanisms by which ID1 protein promotes cell proliferation may involve multiple signaling pathways in different cancer cells. For example, in prostate cancer cells, ID1 promotes cell proliferation by inactivating the p16/pRB pathway (34) . ID1 protects nasopharyngeal carcinoma cells from taxolinduced death through the Raf/MEK pathway (6) . Activation of the MAPK signaling pathway is thought to be another mechanism responsible for ID1-induced cancer cell proliferation (27) . In addition, ID1 may activate the phosphatidylinositol 3-kinase/Akt/NF-B signaling pathway and thereby lower TNF-␣-induced apoptosis in esophageal cancer cells (23) . Similar antiapoptosis effects of ID1 have been reported in breast cancer cells through p53 and NF-B pathways (20) . There is increasing evidence showing that the antiapoptotic functions of ID1 may be achieved, at least partially, by activation of the NF-B pathway, leading to greater expression of its downstream target genes (20, 23, 26) .
The NF-B family is a group of transcriptional factors, consisting of p65 (RelA), RelB, p50 (NF-B1), p52 (NF-B2), and c-Rel (12, 22) . Among these members, p65 and p50 are ubiquitously expressed while the other three are tissue specific. The p65 protein is the most studied member of the NF-B family. All these proteins contain the NH 2 -terminal Rel homology domain, which is responsible for forming homodimers or heterodimers with other NF-B members, interacting with IB proteins, or binding to target DNA (22) . p65 protein contains an additional COOHterminal transactivation domain (TAD) and a linker region between the two domains, encoding nuclear localization sequences (32) . Under unstimulated basal conditions, the p50/p65 dimer predominantly forms an inactive complex with the inhibitory protein of IB and locates within the cytoplasm. When the cell is stimulated, the inhibitory protein IB is phosphorylated and degraded, thus releasing p50/p65 dimer, which is then able to translocate into the nucleus and activate the target genes (5) . The p50/p65 dimer can activate a variety of genes involved in cell proliferation, apoptosis and migration, such as Bcl-2 and Bax, and thus provide protection from drug or cytokine-induced apoptosis in cancer cells (3, 13, 18) .
Recent studies by several groups have revealed that ID1 activates the NF-B signaling pathway in a variety of cells (20, 23, 26, 47) . In general, increased ID1 expression leads to upregulation of NF-B activity. However, the activation pro-cess differs in various cell lines: increased expression of both p65 and p50 proteins while decreased level of total IB occurs in androgen-independent LNCaP prostate cells (26) ; induction of phosphorylation of IB and nuclear localization of p65 with sustained expression of total p65 occurs in HKESC-3 esophageal cells (23) ; and upregulation of both expression and nuclear translocation of p65 with downregulation of total IB expression occurs in MCF-7 breast cancer cells (20) .
Although these studies point to an important role for ID1 in regulating the NF-B signaling pathway in cancer cells, the underlying mechanism by which ID1 regulates NF-B and whether this regulation is achieved by direct interaction or via other mechanisms still need to be elucidated. In this study, we have demonstrated a physical interaction between ID1 and p65 proteins by using an in vitro pull-down assays and coimmunoprecipitation methods. We confirmed the in vivo interaction between ID1 and p65 using a cell-based two-hybrid system. We further identified that the TAD domain in p65 and the HLH domain in ID1 are vital regions for their interaction. Additionally, we demonstrated a functional interaction between ID1 and p65 leading to activation of the NF-B signaling pathway based on luciferase reporter assays. Finally, we found that the regulatory role of ID1 in TNF-␣-induced p65 recruitment to its target promoter may be achieved by interfering with the nuclear translocation of p65. In summary, our results show for the first time that ID1 activates the NF-B signaling pathway through its physical and functional interaction with p65.
MATERIALS AND METHODS

Plasmids and siRNAs.
The vectors pcDNA-Flag-ID1WT, pcDNAFlag-ID1Y67D, pcDNA-Flag-ID1L76H, pcDNA-Flag-ID1K91E, and pcDNA-Flag-ID1Y101D were gifts from Dr. Y. C. Wong (49) . Human ID2 and ID3 cDNA clones in pOTB7 vector were purchased from Openbiosystems. The full-length rat ID1 (rID1) cDNAs were PCR amplified from first-strand cDNA of rat lung with corresponding primer sets ( Table 1) . The digested PCR fragments of human ID1, ID2, and ID3 and rat ID1 were cloned into pCMV-BD vector through BamH1-EcoR1 sites, resulting in four vectors; pCMV-BD-ID1, pCMV-BD-ID2, pCMV-BD-ID3, and pCMV-BD-rID1. A series of truncated rID1 in pCMV-BD vector (pCMV-BD-rID1N102, pCMV-BD-rID1N60, pCMV-BD-rID1C46, pCMV-BD-rID1C88, and pCMV-BD-rID1HLH) were generated by PCR amplification with the primer sets listed in Table  1 . Human ID1 with a single site mutation was generated by PCR using pcDNA-Flag-ID1Y67D, pcDNA-Flag-ID1L76H, pcDNA-Flag-ID1K91E, and pcDNA-Flag-ID1Y101D as templates and inserted into a pCMV-BD vector, resulting in pCMV-BD-ID1Y67D, pCMV-BD-ID1L76H, pCMV-BD-ID1K91E, and pCMV-BD-ID1Y101D. A hemagglutinin (HA)-tagged full-length mouse p65 overexpression vector (pcDNA-HA-p65WT) was provided by Dr. G. Zhang (Oklahoma State University). A series of truncated constructs of p65 were generated by QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene, Santa Clara, CA) with corresponding primer sets (Table 1) . To overexpress His-tagged SUMO p65 transcriptional activation domain (p65TAD) in Escherichia coli, p65TAD was generated by PCR amplification and inserted into a modified pET vector as a SUMO fusion with an NH 2-terminal 6xHis (pET-p65TAD). The open reading frame of ID1 was PCR amplified and cloned as a SUMO fusion in an identical way (pET-ID1). The miR-30a-based short hairpin RNA constructs targeting to ID1 or nonspecific control were prepared by incorporating the small interfering (si)RNA encoding sequences (for Id1: 5=-GTTCCAACTTCGGATTC-CGAG-3=; for control: 5=-ACGTGACACGTTCGGAGAATT-3=) into the miR-30a backbone and then placing them at the 3=-untranslated region of pENTR-EGFP vector. All constructs were subsequently confirmed by DNA sequencing. Chemical synthesized siRNAs against human ID1 (siID1) or nonspecific control (siCon) were purchased from GenePharma (Shanghai, China).
Cell culture and transfection. Human 293T, A549, and HeLa cells were purchased from American Type Culture Collection (Manassas, VA) and maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 pg/ml streptomycin in a 5% CO 2 humidified incubator at 37°C. Plasmid DNA was purified using Qiagen Maxiprep kit columns (Qiagen, Hilden, Germany). One day before transfection, cells were plated in 100-mm plates for coimmunoprecipitation assays and chromatin immunoprecipitation (ChIP) assays or 24-well plates for the mammalian cell two-hybrid assay with dual-luciferase reporters. Approximately 80% confluent cells were transfected by using METAFECTENE EASY (Biontex Laboratories, Martinsried/Planegg, Germany) or Lipofectamine 2000 (Invitrogen) according to the manufacturers' instructions.
Western blot analysis. Total proteins were extracted with 1ϫ lysis buffer (10 mM Tris·HCl, pH 7.5, 1% Triton X-100, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, and 10 g/ml leupeptin) on ice. Nuclear proteins were extracted with NuclearCytosol Extraction Kit according to the manufacturer's instructions (Keygen, China). Protein samples (30 g) were fractionated by electrophoresis on SDS-PAGE and electroblotted to nitrocellulose membrane. After 1-h blocking with 5% fat-free milk in TTBS (20 mM Tris·HCl, pH 7.6, 150 mM NaCl, 0.1% Tween 20), the blot was incubated with primary antibodies overnight at 4°C. The membrane was washed with TTBS and incubated with horseradish peroxidase- Mammalian two-hybrid system. To identify an interaction between ID1 and p65, we used the mammalian two-hybrid system as described previously (44) . Different ID genes fused with the DNA binding domain of GAL4 in pCMV-BD vector were cotransfected with pCMV-AD vector (Stratagene), which expressed the mouse p65TAD, and two luciferase reporter vectors, pFR-Luc (Stratagene) and phRL-TK (Promega, Madison, WI), were cotransfected into 293T cells. Simultaneously, the pCMV-BD vector containing Rab14 cDNA (10) was transfected instead of the pCMV-AD plasmid to serve as the negative control. After 48 h, the cells were lysed and luciferase activity of the lysates was measured using a dual-luciferase kit (Promega).
Expression and purification of ID1 protein and His-tagged p65TAD SUMO fusion protein.
To prepare the recombinant ID1 protein for in vitro pull-down assay, the ID1 protein was expressed in E. coli Bl21gold DE3 cells as His-tagged SUMO-ID1 fusion. The cells were grown in LB media at 37°C until optical density at 600 nm reached 0.7. The cells were then cooled to 18°C, and 1 mM IPTG was added subsequently for induction. The cells were then continuously incubated in the shaker for an additional 15 h before being harvested by centrifugation. The cell pellets were resuspended in binding buffer A (20 mM Tris, 500 mM NaCl, 10% glycerol, 20 mM imidazole, pH 8.0) and lysed by sonication. The lysate was cleared by centrifugation at 20,000 g for 30 min. The supernatant was incubated with 2 ml Ni NTA-agarose beads and after extensive washing with buffer A, the fusion protein was eluted from the Ni-NTA column by buffer A containing additional 250 mM imidazole. Ulp1 enzyme was added to remove the HisSUMO moiety and the protein mixture was then dialyzed overnight at 4°C against buffer C (20 mM Tris, 250 mM NaCl, 10% glycerol, pH 8.0) to remove the imidazole. The protein mixture was then subjected to a second subtracting Ni-NTA column to remove the HisSUMO fragment, the His-tagged Ulp1, and any uncleaved material. Nontagged ID1 was collected as flow-through from the Ni column. Mutant ID1 proteins were produced using a similar method.
The p65TAD was expressed as His-tagged SUMO fusion in E. coli with the identical method as ID1 and extracted from cell lysate using a one-step Ni-NTA affinity purification. Finally, the purified recombinant proteins were flash frozen and stored at Ϫ80°C (7). The purity of all the protein samples was evaluated by SDS-PAGE.
In vitro pull-down assay. To confirm an interaction between ID1 and the TAD domain of p65 proteins, we carried out in vitro His pull-down assays using a similar approach as described previously (24) . Briefly, the purified ID1 and the purified His-p65TAD proteins were incubated at 4°C for 2 h with gentle shaking in the binding buffer and then immobilized with a Ni-NTA affinity column. After being washed three times with cold binding buffer, soluble protein fractions were eluted with elution buffer and separated by SDS-PAGE. Presence of ID1 in the His-p65-ID1 complex was identified by Western blotting.
Native coimmunoprecipitation assay. To further study the functional interaction between ID1 and p65 proteins, the Flag-tagged ID1 and HA-tagged p65 expression vectors were cotransfected into 293T cells. The corresponding truncated vectors of Flag-ID1 and HA-p65 were transfected simultaneously. Forty-eight hours after transfection, cells were washed with PBS and lysed in mRIPA buffer (50 mM Tris, 150 mM NaCl, 1% NP-40, 0.25% deoxycholate, pH 7.4) with protease inhibitor Cocktail (Roche). Immunoprecipitation was performed with the FLAG HA tandem affinity purification kit per the manufacturer's instructions (Sigma). In brief, cell lysates were incubated with antiFlag M2 affinity resin or anti-HA agarose affinity resin at 4°C. The next day, the resins were washed with lysis buffer three times. Then the complexes on the anti-Flag M2 affinity resin and anti-HA-agarose affinity resin were eluted with 3ϫ Flag peptide (150 ng/ml) and urea (8 M) at 4°C for 30 min, respectively. The eluted fractions were then analyzed by Western blotting. An interaction between endogenous ID1 and p65 was determined by immunoprecipitation in A549 cells.
NF-B signaling pathway reporter assay. NF-B reporter assay was performed in human cervical cancer HeLa cells seeded on 24-well plate by cotransfecting either the shID1 vector or the Flag-ID1 vector along with a firefly luciferase reporter vector containing NF-B binding sites in its promoter region (Clontech, Mountain View, CA) and a second Renilla luciferase reporter vector of phRL-TK for the normalization of transfection efficiency. The corre- sponding control vectors were also included. Forty-eight hours after transfection, the cells were treated with 10 ng/ml of human recombinant TNF-␣ (R & D Systems, Minneapolis, MN) or medium as negative control. Then the cells were washed with PBS and lysed for dual-luciferase assay. Luciferase activity of the firefly luciferase was normalized against that of Renilla luciferase.
Quantitative RT-PCR. HeLa cells were transfected with siRNAs targeting ID1 (siID1) or the control siRNAs (siCon). After 72 h of transfection, the cells were treated with 10 ng/ml TNF-␣ for 1 h. Total RNA was extracted with RNAiso reagent (TaKaRa Biotechnology, China) and treated with an RNase-Free DNase (TaKaRa). Total RNA (1 g) was reversely transcribed using M-MLV Reverse Transcriptase (TaKaRa) with random hexamer primers (TaKaRa). Quantitative RT-PCR was carried out with gene-specific primers and SsoFast EvaGreen Supermix (Bio-Rad) on ABI 7300 real-time PCR System (Applied Biosystems, Carlsbad, CA). The expression level of cellular inhibitor of apoptosis protein 2 (cIAP2) gene was normalized to the internal control GAPDH gene using the 2 Ϫ⌬⌬CT method. The primers were applied as the former reported experiments (42) listed as follows: cIAP2, sense (5=-CTTGTCCTTGCTGGTGCAT-3=) and antisense (5=-AAGAAGTCGTTTTCCTCCTTTGT-3=); GAPDH, sense (5=-AGCCACATCGCTCAGACAC-3=) and antisense (5=-GCCC-AATACGACCAAATCC-3=).
Electrophoretic mobility shift assays. HeLa cells were transfected with siID1 or siCon for 72 h and were then treated with 10 ng/ml TNF-␣ for 45 min. The oligonucleotide probe for EMSA corresponded to the one of the NF-B binding sites in the cIAP2 promoter according to previous reports (sense, 5=-TTATTACCGCTGGAG-TTCCCCTAAGTC-3= and antisense, 5=-GACTTAGGGGAACTC-CAGCGGTAATAA-3=) (17) . The NF-B binding site is shown as underlined sequences. Each oligonucleotide was labeled with biotin using EMSA Probe Biotin Labeling Kit (Beyotime) per the manufacturer's instructions. The biotin-labeled complementary oligonucleotides were then annealed to generate a double-stranded probe. Nuclear extract (10 g) was mixed with ϳ20 fmol of the labeled probe in a total volume of 10 l of binding buffer. After incubation at room temperature for 20 min, the reaction mixtures were then separated by electrophoresis through a 6% nondenaturing polyacrylamide gel in 0.5ϫ Tris-borate-EDTA buffer (pH 8.3) at 100 V for 1 h. The bound and free probes in the gel were transferred to a Hybond-Nϩnylon membrane (Amersham) at 380 mA for 1 h. The probes on the membrane were detected using Chemiluminescent EMSA Kit (Beyotime) as instructed. For competition experiments, a 100-fold molar excess of the unlabeled double-stranded probe was added 10 min before the addition of the labeled probe. ChIP assay. ChIP assay was applied to investigate whether ID1 influences the recruitment of p65 to its downstream target promoter. HeLa cells transfected with siID1 or siCon were stimulated with 10 ng/ml of TNF-␣. ChIP assays were carried out with the EZ ChipTM Assay kit (Upstate Biotechnology, Lake Placid, NY) according to the manufacturer's instructions. Briefly, the chromatin fraction was immunoprecipitated with p65 antibody. Parallel controls for each experiment included samples with the normal rabbit IgG (negative control) and the input (positive control). After elution and purification, the recovered DNA samples were used as template for regular PCR (GoTaq polymerase, Promega) or real-time PCR (SsoFast EvaGreen Supermix, Bio-Rad) according to the manufacturers' instructions. The specific primers for promoter cIAP2 and GAPDH promoters were listed as follows: cIAP2 sense (5=-AGCTCAGGCCTCAAGACCTT-3=) and antisense (5=-AAGAAGATGCGGCTGACTGT-3=); GAPDH sense (5=-CACGAGCAATGAAGCAAATG-3=) and antisense (5=-GTGCACTGGTGCTTTCCTTT-3=) according to former reported experiments (28, 48) . Pull-down level of a target promoter sequence was normalized to the corresponding abundance in the input chromatin, and the regulatory effect is represented as percentage relative to that in the control siRNA-transfected cells.
Statistical analyses. Each experiment was repeated at least three times. Data are presented as mean values with standard deviation. Statistical analysis of the data was performed using a standard twosample Student's t-test. Statistical significance was determined using a two-tailed distribution assumption and was set at 5% level (P Ͻ 0.05).
RESULTS
ID1 physically binds p65 in vitro and in vivo.
To study the interaction between purified ID1 and p65, His-tagged p65TAD was purified. After preincubation of purified ID1 with Histagged p65TAD, free and bound ID1 to p65TAD was separated using affinity chromatography. As shown in Fig. 1, A and B , the input ID1 proteins were coeluted with His-tagged p65TAD and confirmed by Western blotting with ID1 and p65 antibodies. We also looked for interaction between ID1 and His-IB␣ or -p50; however, we did not see any significant binding between ID1 and IB␣ or p50 (data not shown).
To further confirm interaction between ID1 and p65TAD, we transiently cotransfected the expression vectors containing Flag-ID1 and HA-p65TAD constructs into 293T cells. As shown in Fig. 1, C and D, Western blotting showed that, in total cell lysates, Flag (Fig. 1C, line 1) or HA (Fig. 1D, line 1) was detected in the cells transfected with FLAG-ID1 or HAp65TAD and the cells cotransfected with HA-p65TAD and FLAG-ID1. After immunoprecipitation with anti-HA affinity resin, a HA-p65TAD band was detected in the cells transfected with HA-p65AD or cotransfected with both Flag-ID1 and HA-p65TAD (Fig. 1C, line 2) , indicating successful immunoprecipitation with anti-HA antibody. Interaction between ID1 and p65TAD was observed only in the cells cotransfected with the two expression plasmids by immunoblotting with anti-FLAG antibody (Fig. 1C, line 3, lane 1) . No complexes were detected in the cells transfected with one expression plasmid. However, after immunoprecipitation with anti-FLAG affinity resin, HA-p65TAD was detected in the cells cotransfected with two expression plasmids (Fig. 1D, line 3, lane 1) . These data provide additional evidence that p65TAD and ID1 interact. To further prove the presence of interaction between endogenous ID1 and p65, A549 cells that express low levels of endogenous ID1 were selected for immunoprecipitation with either ID1 or p65 antibodies. Indeed, specific ID1-p65 complexes were readily detectable from lysates by immunoprecipitation with anti-ID1 antibodies or anti-p65 and blotting with anti-p65 (Fig. 1E,  lane 3) or anti-ID1 antibodies, respectively (Fig. 1F, lane 1) . Taken together, these results indicate the existence of an in vivo physical interaction between ID1 and p65.
Identification of regions responsible for ID1-p65 interaction. To identify the binding domain of p65 to ID1, we constructed five vectors that expressed wild-type p65 or truncated p65 fused with HA tag: the HA-p65WT, HA-p65⌬370 -426, HA-p65⌬426 -526, HA-p65⌬426 -550, and HA-p65⌬526 -550 (Fig. 2A) . The ⌬ represents the deletion of the corresponding amino acids from the full-length p65 protein. These four HA-p65 truncates and the wild-type Flag-ID1WT vector were then cotransfected into 293T cells, and the whole cell lysates were immunoprecipitated with anti-FLAG M2 affinity resin. Figure 2B shows that all of the Flag-ID1 proteins were detected in the precipitates (line 1, lanes [1] [2] [3] [4] [5] , indicating successful immunoprecipitation of the Flag protein. HA-p65 bands were detected in cells transfected with HAp65-WT, HA-p65 ⌬370 -426, and HA-p65 ⌬426 -526 that lacked the TA-2 domain of p65 protein (Fig. 2B, line 3, lanes 1, 3, and  4) . In contrast, low-intensity bands of HA-p65 were observed in cells transfected with HA-p65 ⌬526 -550 (Fig. 2B, line 3, lane 2) that lacked the TA-1 domain of p65 protein. The HA-p65 band was undetectable in cells transfected with HA-p65 ⌬426 -550 (Fig. 2B, line 3, lane 5 ) that lacked the whole TAD domain.
Similar results were obtained from lysates by immunoprecipitation with anti-HA antibody and blotting with anti-FLAG (Fig. 2C,  bottom) . These results suggest that the TAD domain of p65 protein may play an essential role in the interaction between p65 and ID1.
We next proceeded to identify the binding site in ID1 for its interaction with p65TAD. We constructed four mutants that contained point mutations of ID1 HLH domain fused with FLAG tag: FLAG-ID1-Y67D, FLAG-ID1-L76H, FLAG-ID1-K91E, and FLAG-ID1-Y101D (Fig. 2D) . These mutants were cotransfected with the vector encoding HA-tagged full-length p65 into 293T cells, and the whole cell lysate was immunoprecipitated with anti-HA agarose affinity resin. Lines 1 and 2 of Fig. 2E demonstrate that the HA-p65 and Flag-ID1 proteins were detected in the corresponding lysates, indicating successful expression of the corresponding plasmids. Flag-ID1 protein bands were identified in cells transfected with Flag-ID1-WT, FLAG-ID1-Y67D, and FLAG-ID1-K91E (Fig. 2E, line 3,  lanes 2, 3, and 5, respectively) . However, no Flag-ID1 band was detected in cells transfected with FLAG-ID1-L76H and FLAG-ID1-Y101D (Fig. 2E, line 3, lanes 4 and 6) , suggesting that the HLH domain of ID1 protein may be essential for the interaction between p65 and ID1. Moreover, two amino acids, Leu76 and Tyr101, may be crucial for binding activity.
To further investigate the importance of these two binding sites of ID1 to p65 protein, we examined the effects of the single site mutation in Leu76 or Tyr101 of ID1 on its interaction with p65TAD by His-tag pull-down assays with the purified ID1 WT or its mutants (ID1-L76H, ID1-Y101D) and the purified His-tagged SUMO-p65TAD fusion protein. We found that with the same amount of input proteins (Fig. 2G,  lanes 1, 2, and 3, respectively) , the bound ID1 proteins from the pull-down assays were quantified by Western blotting with ID1 antibodies (Fig. 2G, top) . Compared with the ID1-WT, a single site mutation at Tyr101 led to a 27% reduction in binding while mutation at Leu76 reduced binding by 65% (Fig.  2H) , indicating that both sites are necessary for ID1 binding to p65TAD while Leu76 site is more essential.
Detection of a functional interaction of ID1 and p65 using a mammalian two-hybrid system. To further verify an interaction between the HLH domain of ID1 and the TAD domain of p65, we constructed a series of mutants and truncated ID1 variants that were inserted into pCMV-BD vector. These pCMV-BDbased ID1 vectors were cotransfected into 293T cells along with two luciferase reporter vectors (pFR-Luc and phRL-TK) and pCMV-AD vector that expresses mouse p65TAD. As shown in Fig. 3A , compared with a control vector of Rab14 in pCMV-BD, cotransfection of ID1-WT with pCMV-AD led to an over 30-fold increase in normalized luciferase activity, indicating that a physical interaction may exist between ID1 and p65TAD. Single site mutation at Y67 or K91 reduced by around 70% and 30%, respectively, luciferase activity compared with the ID1-WT (Fig. 3A) . Similar as above coimmunoprecipitation data (Fig. 2, E and F) , mutation at L76 or Y101 almost abolished luciferase activity to the baseline level (Fig.  3A) , indicating that these two sites are very important to maintain proper structure of ID1 for interaction with p65TAD. To examine whether other ID proteins have similar interaction with p65TAD, we constructed three pCM-BD vectors with full-length cDNA of rat ID1, ID2, or ID3 inserts. Using the mammalian two-hybrid assay, we demonstrated that all tested ID proteins were able to interact with p65TAD although interaction with ID2 was relatively less compared with ID1 and ID3 (Fig. 3B) . We further constructed five truncates containing truncated rat ID1 gene fused with Gal4 in pCMV-BD vectors and cotransfected with pCMV-AD vector into 293T cells. As shown in Fig. 3, C and D, the HLH-deleted ID1 (N60 and C46) showed almost the basal luciferase reading, while the constructs with existing HLH domain still had partial activity. Taken together, our data demonstrate an essential role of the ID1 HLH domain in its binding ability to p65TAD.
Interaction between ID1 and p65 regulates TNF-␣-stimulated NF-B activation. To determine biological significance for ID1 protein binding to p65, we suppressed ID1 expression in HeLa cells and performed TNF-␣ treatment. We found that Fig. 5 . ID1 regulates the nuclear translocation of p65 and its consequent recruitment to the target promoter. A and B: ID1 inhibits the nuclear translocation of p65. HeLa cells were transfected with either siID1 or siCon and then treated with 10 ng/ml of TNF-␣ for 45 min. A: p65 protein levels in total and nuclear lysates were measured with Western blotting. Histone H3 and ␤-actin antibodies were used as internal controls for the nuclear and total fractions, respectively. B: nuclear extracts were assessed by EMSA as described in MATERIALS AND METHODS. The complex could be completed by unlabeled probe (cold), as indicated. C-E: suppression of ID1 attenuates TNF-␣-induced recruitment of p65 on cIAP2 promoter. HeLa cells were transfected with either siID1 or siCon and then treated as in A. Cell lysates were used for chromatin immunoprecipitation (ChIP) analysis. C: regular PCR was performed on the promoter of one NF-B-targeting gene, cIAP2, while GAPDH promoter was used as a non-NF-B-targeting control. PCR products were run on 2.5% agarose gels. D: quantitative real-time PCR was carried out and the pull-down cIAP2 promoter in each sample was normalized against the corresponding input DNA. E: the promoter level in ID1 suppressed cells is represented as a percentage of that in control cells. Analysis was carried out using Student's t-test. *P Ͻ 0.05. under resting status, there was no significant difference between the ID1-suppressed cells and the control cells (Fig. 4B) . After TNF-␣ stimulation, the activation activities of NF-B response reporter vectors in control cells sharply increased to more than 2.5-fold. By contrast, the trans-activation activities of NF-B response vectors were around 60% relative to that of the control, suggesting the important role of ID1 in TNF-␣-induced NF-B trans-activation.
Meanwhile, we also overexpressed ID1 in HeLa cells by using the Flag-ID1 vector. We observed significant higher activities in ID1 overexpressed HeLa cells under TNF-␣ stimulation compared with that in the control cells (Fig. 4D) , consistent with our former results on the activation role of ID1 in p65 stimulation.
In addition, we checked whether TNF-␣-induced expression of NF-B-dependent target gene was affected by ID1. HeLa cells were transfected with siID1 or control siRNA and treated with TNF-␣ for 1 h. Western data showed that ID1 expression was significantly suppressed in siID1-transfected HeLa cells compared with that in the control (Fig. 4E ). Extracted total RNA was used to measure endogenous mRNA levels of cIAP2 by quantitative real-time PCR. As shown in Fig. 4F , the induction of cIAP2 expression upon TNF-␣ stimulation was attenuated to around 75% when ID1 was suppressed compared with the siRNA control group, indicating that ID1 regulates the expression of TNF-␣-induced NF-B-dependent target gene.
Suppression of ID1 inhibits p65 nuclear translocation and its recruitment to target promoter. To investigate how ID1 modulates NF-B signaling, we examined whether ID1 affects the expression of p65 or its nuclear translocation. HeLa cells transfected with siID1 or siCon without or with TNF-␣ treatment were used to measure the total and nuclear p65 protein levels by Western blotting. The results showed that total p65 protein did not change obviously. However, the nuclear p65 level was significantly decreased due to the loss of ID1 under both unstimulated and TNF-␣-stimulated conditions when compared with each control (Fig. 5A) , suggesting that suppression of ID1 probably leads to less NF-B activation. To explore this, we prepared nuclear extracts from siID1 or siCon-transfected HeLa cells and determined NF-B activation by EMSA using cIAP2 promoter sequences, which were reported to contain the canonical Ϫ147 NF-B DNA-binding site (14) . As shown in Fig. 5B , suppression of ID1 significantly reduced the binding of labeled probe in both unstimulated and stimulated samples when compared with the corresponding controls. Coincubation with the unlabeled probe in TNF-␣-treated samples significantly reduced the amount of bound probe. These data further support that ID1 influences the activity of NF-B.
To explore whether knockdown of ID1 expression leads to less recruitment of p65 to its dependent promoter, we carried out ChIP assay to check the recruitment of p65 to its target cIAP2 promoter (14) . HeLa cells were transfected with either siID1 or control siRNAs, then treated with 10 ng/ml of TNF-␣ for 45 min. The cross-linked DNA was immunoprecipitated with either a p65 antibody or a negative control of rabbit IgG and then applied for quantitative PCR targeting cIAP2 promoter region. Simultaneously, GAPDH promoter was also examined as a nontargeting control. From the initial semiquantitative PCR results, it was clearly shown that the PCR products targeting to cIAP2 promoter were weaker in siID1-trans- fected cells when compared with siCon (Fig. 5C) . No PCR products were obtained at the GAPDH promoter (Fig. 5C) , demonstrating that the chromatin association of p65 to cIAP2 promoter is gene specific. As shown in Fig. 5D , quantitative real-time PCR assay data showed that the pull-down cIAP2 promoter sequences were detectable in both siID1 and siContransfected cells, whereas the levels of GAPDH promoter sequences were close to zero when normalized to the inputs. The recruitment of p65 to its target cIAP2 promoter was decreased to around 30% due to the loss of ID1 (Fig. 5E) . The less recruitment of p65 binding to the cIAP2 promoter was consistent with the decrease of nuclear p65 in ID1 suppressed cells, indicating that ID1 was essential in TNF-␣-induced p65 recruitment to cIAP2 promoter.
DISCUSSION
In this study, we have identified a direct in vitro interaction between ID1 and p65 with pull-down assay and confirmed the existence of their physical in vivo interaction using coimmunoprecipitation methods. In addition, we have determined that the HLH domain of ID1 and the TAD domain of p65 are essential for their binding. Furthermore, we have demonstrated that binding of ID1 with p65 might be crucial for NF-B activation to its downstream target gene induced by TNF-␣ treatment. Consistent with these findings, lowered ID1 expression inhibited the TNF-␣-induced nuclear translocation of p65 and consequently suppressed p65-regulated cIAP2 transcriptional activation on TNF-␣ stimulation. Our results identified that the physical interaction between ID1 and p65 may contribute at least partially to ID1-induced activation of downstream NF-B signaling pathways in cancer cells, which may play a role in modulating cell response to TNF-␣ stimulation.
Previous studies have established the inhibitory effects of ID1 in muscle cell differentiation through the interaction between its HLH domain and the target HLH proteins (11, 30) . Recent studies have revealed that ID1 also binds to and therefore regulates activities of non-HLH proteins. For example, ID1 inhibits the transcriptional activity of Ets2 through their direct interaction, resulting in reduction of replicative senescence in young human diploid fibroblasts (31) . It has also been reported that ID1 interacts with the Pax transcription factors and thus downregulates their DNA binding ability and their regulation of cellular differentiation progression (36) . A recent study has shown that ID1 physically interacts with a non-HLH protein, caveolin-1 (Cav-1), a primary cell membrane protein and acts as an oncogene in prostate cancer (49) . The HLH domain of ID1 was found to be responsible for its physical interaction with Cav-1 and its functional activation of the downstream Akt pathway. In this study, our results demonstrate the physical and functional interaction between ID1 and NF-B. Furthermore, we have identified the binding site of ID1 to be located in the HLH domain, which is consistent with earlier reports indicating the HLH domain of ID1 protein as the main binding domain with other proteins (11, 49) . Deletion of HLH domain almost abolished the ability of ID1 to bind p65, suggesting the importance of the HLH domain for the physical interaction between ID1 and p65.
Interestingly, we found that a single site mutation (Leu76 or Tyr101) in the HLH domain of ID1 protein almost abolished the physical interaction between ID1 and p65 (Fig. 2E) . We also confirmed the negative effects of these two ID1 mutations on the ID1-p65TAD interaction using an in vitro pull-down assay, though the Leu76 seemed to reduce this interaction to a greater degree (Fig. 2H) . This difference may be due to variation in the sensitivity of the various experimental methods. Nevertheless, our data indicate that the interaction between ID1 and p65 is mediated by the HLH domain of ID1 and L76 and Y101 may be important for this interaction. In fact, the HLH domain is highly conserved among human ID protein family, as well as its orthologs among other species (Fig. 6, A  and B) . Interestingly, L76 and Y101 are strictly conserved among all these species while neither Y67 nor K91 is fully conserved. This homology analysis also points to the importance of the L76 and Y101 residues in ID1 binding ability.
To study the structure and function properties of ID1, we carried out a three-dimensional (3-D) structure analysis of the HLH domain of ID1 protein by homology modeling with Swiss-Model server (41) . As shown in Fig. 7, 3 -D modeling showed that both L76 and Y101 are located in a large hydrophobic patch on the surface of the HLH domain and are solvent exposed, indicating their potential roles in protein interactions. Perturbations at these locations may result in significantly reduced binding to p65. In fact, the important role of Y101 was also reported previously in the association of ID1 with Cav-1 (49) . Further detailed structural studies need to be carried out to reveal the molecular mechanism by which ID1 interacts with p65.
ID1 was widely reported to be an inhibitor of the transcription activity of its binding partners (30) . In contrast, our results show that the interaction between ID1 and p65 prompted the TNF-␣-stimulated NF-B signaling pathway (Fig. 4) . This effect is consistent with other studies on the role of ID1 in Fig. 7 . L76 and Y101 are positioned on the surface of ID1. The structure of the HLH domain of human ID1 was constructed by homology modeling, using Swiss-Model server. Left: the secondary structure is shown as ribbons and the L76 and Y101 residues are shown as sticks with dotted envelopes indicating the van der Waals radius. Right: electropotential surface of HLH domain. Blue, positive; red, negative. L76 and Y101 are located in a hydrophobic patch (shown in white) on ID1 surface, which might be involved in protein interactions.
activating the NF-B signaling pathway in cancer cells (20, 23, 26) . Activation of the NF-B pathway leads to the increased expression of a variety of its targeting genes, which in turn promotes cell proliferation and migration (1, 18) . Our study demonstrated that the interaction of ID1 with p65 is crucial for activation of the NF-B pathway using luciferase reporter assay. We also identified that ID1 affects the TNF-␣-stimulated expression of cIAP2 gene, which was identified as one of the critical repressors of apoptosis (17, 28) , suggesting one mechanism by which ID1 promotes cancer cell survival. In former studies, p65 was reported to directly activate the cIAP2 expression following TNF-␣ stimulation (17, 28) . Likewise, we observed the p65 recruitment to the cIAP2 promoter, but not the negative control GAPDH promoter, in TNF-␣-stimulated HeLa cells. Furthermore, our ChIP data showed that less recruitment was obtained in ID1-suppressed cells, which is in agreement with our hypothesis that ID1 might play an important role in NF-B activation in cancer cells. A possible explanation for the oncogenic effect of ID1 is that the high levels of ID1 in cancer cells may promote NF-B activation under TNF-␣ stimulation, which consequently leads to higher survival and invasive abilities. However, the detailed mechanism by which ID1-p65 interaction activates NF-B signaling needs investigation. We have identified that ID1 regulates the nuclear translocation of p65 upon TNF-␣ stimulation in HeLa cells. Future work must focus on resolving these relevant ID1-associated proteins such as IB␣ and p300 (28) that play role in the NF-B complex formation and nuclear translocation during p65 activation.
In summary, our findings demonstrate the physical and functional interaction between ID1 and NF-B, which provides some clue as to how ID1 regulates NF-B signaling pathways in cancer cells. Our data also shed some light on the molecular mechanisms by which ID1 promotes cancer cell survival and progression, suggesting that targeting ID1 at a molecular level may be a potential anticancer therapy in the future.
